Patient Condition
End-stage ischemic cardiomyopathy, LVEF 12%, NYHA class IV, multiple cardiogenic shock attacks. The coronary lesion is diffuse and revascularization is impossible, and a heart transplant is waiting.
Treatment Timeline
| Phase | Details | Date |
|---|
| Assessment of bridging therapy | | |
| LVAD implantation | | |
| Postoperative ICU and rehabilitation | | |
| Migration Bridge Management | | |
Treatment Outcome
| before | LVEF 12%, NYHA class IV, recurrent cardiogenic shock, INTERMACS class 2 |
|---|
| after | Cardiac output returned to normal after LVAD support, NYHA class II, INTERMACS class 6-7, successfully awaiting transplantation |
|---|
| highlight | LVAD as a bridging therapy improves end-stage patients from INTERMACS level 2 to 6-7, successfully transitioning to transplantation |
|---|